ストックスクリーナーアプリを入手
1.43
2.88%
0.04
プレマーケット:
1.38
-0.05
-3.50%
前日終値:
$1.39
開ける：
$1.41
24時間の取引高:
331.39K
Relative Volume:
0.44
時価総額：
$44.84M
収益：
-
当期純損益:
$-69.00M
株価収益率:
-0.5144
EPS:
-2.78
ネットキャッシュフロー:
$-55.26M
1週間 パフォーマンス:
+5.93%
1か月 パフォーマンス:
+7.52%
6か月 パフォーマンス:
-73.76%
1年 パフォーマンス:
-82.92%
1日の値動き範囲:
$1.34
$1.47
1週間の範囲:
$1.34
$1.495
52週間の値動き範囲:
$1.05
$10.16
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
名前
Acrivon Therapeutics Inc
セクター
電話
617-207-8979
住所
480 ARSENAL WAY, SUITE 100, WATERTOWN
ACRV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.43 | 43.58M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-05 | 再開されました | Piper Sandler | Overweight |
| 2025-01-31 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-12-15 | 再開されました | Jefferies | Buy |
| 2023-10-05 | 開始されました | Maxim Group | Buy |
| 2023-06-02 | 開始されました | Oppenheimer | Outperform |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-04-27 | 開始されました | Ladenburg Thalmann | Buy |
| 2023-04-20 | 開始されました | H.C. Wainwright | Buy |
| 2022-12-12 | 開始されました | Cowen | Outperform |
| 2022-12-12 | 開始されました | Jefferies | Buy |
| 2022-12-12 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Acrivon Therapeutics Inc (ACRV) 最新ニュース
Detecting support and resistance levels for Acrivon Therapeutics Inc. Predictable Entry Strategy With Technical Backing - Newser
Statistical indicators supporting Acrivon Therapeutics Inc.’s strength Safe and Scalable Return Strategy Blueprint - Newser
How strong is Acrivon Therapeutics Inc. company’s balance sheetMarket Forecast Data Feed Backed By Experts - jammulinksnews.com
How does Acrivon Therapeutics Inc. generate profit in a changing economyInvest confidently with real-time updates - jammulinksnews.com
When is Acrivon Therapeutics Inc. stock expected to show significant growthUnlock real-time stock alerts for quick profits - jammulinksnews.com
What are Acrivon Therapeutics Inc. company’s key revenue driversOverwhelming profit margins - jammulinksnews.com
What are the technical indicators suggesting about Acrivon Therapeutics Inc.Build wealth faster with high-performing stocks - jammulinksnews.com
Should I hold or sell Acrivon Therapeutics Inc. stock in 2025Exceptional trading results - jammulinksnews.com
What institutional investors are buying Acrivon Therapeutics Inc. stockFastest-growing stock picks - jammulinksnews.com
What makes Acrivon Therapeutics Inc. stock price move sharplyFree High-Profit Stock Picks - Newser
What are the latest earnings results for Acrivon Therapeutics Inc.Capitalize on emerging market sectors - jammulinksnews.com
Is Acrivon Therapeutics Inc. stock a good hedge against inflationSafe and Smart Investment Picks - Newser
What are analysts’ price targets for Acrivon Therapeutics Inc. in the next 12 monthsDiscover high-impact investment opportunities - jammulinksnews.com
Published on: 2025-07-27 15:59:55 - jammulinksnews.com
Is Acrivon Therapeutics Inc. stock overvalued or undervaluedAccess high-yield investment alerts now - jammulinksnews.com
What is the dividend policy of Acrivon Therapeutics Inc. stockGet timely market insights for better trades - jammulinksnews.com
What analysts say about Acrivon Therapeutics Inc. stockOver 200% growth - PrintWeekIndia
Acrivon Therapeutics Inc. Stock Analysis and ForecastBreakthrough profits - PrintWeekIndia
Is Acrivon Therapeutics Inc. a good long term investmentDynamic investment opportunities - PrintWeekIndia
How high can Acrivon Therapeutics Inc. stock price go in 2025Free Group Entry - Newser
Here's Why We're Watching Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Situation - Yahoo Finance
What drives Acrivon Therapeutics Inc. stock priceHigh-profit capital plays - jammulinksnews.com
Acrivon Therapeutics Inc (ACRV) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):